Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic
暂无分享,去创建一个
Rakesh K. Sharma | J. Reynolds | R. Aalinkeel | S. Mahajan | S. Schwartz | D. Sykes | James Oh | E. Quaye | K. Cwiklinski | R. Sharma | Katherine Cwiklinski
[1] M. Rosini,et al. Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea , 2018, Molecules.
[2] O. Çiftçi,et al. Curcumin protects heart tissue against irinotecan-induced damage in terms of cytokine level alterations, oxidative stress, and histological damage in rats , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] D. Bachvarov,et al. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment. , 2017, Journal of agricultural and food chemistry.
[4] Amjad Ali,et al. Curcumin inhibits HIV-1 by promoting Tat protein degradation , 2016, Scientific Reports.
[5] C. Huang,et al. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. , 2016, Nanoscale.
[6] S. Polyak,et al. Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection , 2015, Viruses.
[7] S. Prasad,et al. Curcumin and its analogues: a potential natural compound against HIV infection and AIDS. , 2015, Food & function.
[8] Tatiana Ammosova,et al. Inhibition of HIV-1 by curcumin A, a novel curcumin analog , 2015, Drug design, development and therapy.
[9] S. Thorgeirsson,et al. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. , 2015, Journal of hepatology.
[10] Zhimei Song,et al. Linolenic acid-modified PEG-PCL micelles for curcumin delivery. , 2014, International journal of pharmaceutics.
[11] Ying Tan,et al. Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage , 2014, Inflammation Research.
[12] Jian-hai Chen,et al. Preparation of novel curcumin-loaded multifunctional nanodroplets for combining ultrasonic development and targeted chemotherapy. , 2014, International journal of pharmaceutics.
[13] A. Ingle,et al. Metal nanoparticles: The protective nanoshield against virus infection , 2014, Critical reviews in microbiology.
[14] Wim E Hennink,et al. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. , 2014, Biomaterials.
[15] H. J. Um,et al. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[16] G. J. Gabriel,et al. Facile synthesis of silver nanoparticles stabilized by cationic polynorbornenes and their catalytic activity in 4-nitrophenol reduction. , 2013, Langmuir : the ACS journal of surfaces and colloids.
[17] S. Shyue,et al. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. , 2012, Molecular nutrition & food research.
[18] J. Snyder,et al. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. , 2012, International immunopharmacology.
[19] Elsa N. Garza Treviño,et al. Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins , 2011, Journal of nanobiotechnology.
[20] Raju C Reddy,et al. Curcumin-Loaded Apotransferrin Nanoparticles Provide Efficient Cellular Uptake and Effectively Inhibit HIV-1 Replication In Vitro , 2011, PloS one.
[21] H. H. Lara,et al. Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds , 2011, Journal of nanobiotechnology.
[22] R. Sharma,et al. Metal nanoparticles with high catalytic activity in degradation of methyl orange: An electron relay effect , 2011 .
[23] Murali M. Yallapu,et al. Poly(β-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells. , 2010, Macromolecular bioscience.
[24] H. Maibach,et al. Nanofibrous materials for wound care , 2010, Cutaneous and ocular toxicology.
[25] R. Das,et al. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[26] C. Rodríguez-Padilla,et al. Mode of antiviral action of silver nanoparticles against HIV-1 , 2010, Journal of nanobiotechnology.
[27] M. Diederich,et al. Effect of Curcumin on Nuclear Factor κB Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells , 2009 .
[28] A. Mathur,et al. Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Fabrication and Characterization of Silk Fibroin-derived Curcumin Nanoparticles for Cancer Therapy , 2022 .
[29] E. Srivatsan,et al. Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway , 2008, Clinical Cancer Research.
[30] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[31] A. Mobasheri,et al. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. , 2007, Biochemical pharmacology.
[32] P. Mukherjee,et al. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. , 2007, International journal of pharmaceutics.
[33] D. Haller,et al. Functional diversity of flavonoids in the inhibition of the proinflammatory NF-kappaB, IRF, and Akt signaling pathways in murine intestinal epithelial cells. , 2006, The Journal of nutrition.
[34] Jie Yin,et al. A simple method for selective immobilization of silver nanoparticles , 2005 .
[35] E. Manheimer,et al. Herbal medicines for treating HIV infection and AIDS. , 2005, The Cochrane database of systematic reviews.
[36] M. Yacamán,et al. Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.
[37] A. Gopalan,et al. Preparation of catalytically efficient precious metallic colloids by γ-irradiation and characterization , 2005 .
[38] Tania Nolan,et al. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. , 2004, Journal of biomolecular techniques : JBT.
[39] Y. Shon,et al. Aqueous synthesis of alkanethiolate-protected Ag nanoparticles using Bunte salts. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[40] Surendra S. Ambegaokar,et al. Curcumin inhibits dose-dependently and time-dependently neuroglial cell proliferation and growth. , 2003, Neuro endocrinology letters.
[41] M. Tsuji,et al. Laser induced morphology change of silver colloids: formation of nano-size wires , 2003 .
[42] N. Sobal,et al. Preparation of silver nanoparticles by interphase reduction , 1999 .
[43] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[44] B. Aggarwal,et al. The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.
[45] A. Fauci,et al. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[46] Zhong Zheng,et al. Current development of silver nanoparticle preparation, investigation, and application in the field of medicine , 2015 .
[47] A. Tiwari,et al. APPLICATION OF SILVER NANOPARTICLES IN VIRAL INHIBITION: A NEW HOPE FOR ANTIVIRALS , 2014 .
[48] R. Rajaram,et al. Curcumin conjugated gold nanoparticle synthesis and its biocompatibility , 2014 .
[49] R. Rajaram,et al. Investigations on the interaction of gold-curcumin nanoparticles with human peripheral blood lymphocytes. , 2011, Journal of biomedical nanotechnology.
[50] T. Horie,et al. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. , 1999, Pharmacological research.
[51] B. Aggarwal,et al. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. , 1995, The Journal of biological chemistry.